Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info


Read Full Text


Download PDF


View Table of Contents

Cyclooxygenase-2 Genotype and Rheumatoid Arthritis

KYU HOON LEE, HEE-SANG KIM, AHMED EL-SOHEMY, MARILYN C. CORNELIS, WAN-SIK UHM, and SANG-CHEOL BAE

ABSTRACT.

Objective. To determine the association between cyclooxygenase-2 (COX-2) genotypes and risk and severity of rheumatoid arthritis (RA) in a Korean population.

Methods. A total of 258 Korean patients with RA and 400 control subjects were recruited from Hanyang University Hospital. Subjects were genotyped for the –765G/C polymorphism of the COX-2 gene by RFLP-PCR analysis. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to estimate risk. Severity of RA was assessed by anatomical stage according to Steinbrocker, et al.

Results. No association was observed between COX-2 genotype and risk or severity of RA. However, among those without the shared epitope (SE), carriers of the low activity C allele had a lower risk of RA and less severe form of RA than subjects with the G/G genotype. The OR (95% CI) was 0.36 (0.14–0.95) for risk of RA and 0.04 (0.01–0.41) for severity.

Conclusion. These results suggest that COX-2 genotyping might be useful in predicting the risk and severity of RA in individuals without the SE. (J Rheumatol 2006;33:1231–4)

Key Indexing Terms:

POLYMORPHISM
CYCLOOXYGENASE-2
SHARED EPITOPE

KOREA
RHEUMATOID ARTHRITIS


From the Department of Physical Medicine and Rehabilitation, Division of Rheumatology, and the Hospital for Rheumatic Diseases, Hanyang University, Seoul; Department of Physical Medicine and Rehabilitation, Kyung Hee University, Seoul; Department of Nutritional Sciences, University of Toronto, Toronto, Canada; and Department of Internal Medicine, Division of Rheumatology, and the Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea.

Supported in part by a grant of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (no. 01-PJ3-PG6-01GN11-0002).

K.H. Lee, MD, Department of Physical Medicine and Rehabilitation, Division of Rheumatology, and Hospital for Rheumatic Diseases, Hanyang University; H-S. Kim, MD, PhD, Department of Physical Medicine and Rehabilitation, Kyung Hee University; A. El-Sohemy, PhD; M.C. Cornelis, BSc, Department of Nutritional Sciences, University of Toronto; W-S. Uhm, MD, PhD; S-C. Bae, MD, PhD, MPH, Department of Internal Medicine, Division of Rheumatology, and Hospital for Rheumatic Diseases, Hanyang University.

Address reprint requests to Prof. S-C. Bae, The Hospital for Rheumatic Diseases, Hanyang University Medical Center, Seoul 133-792, Korea. E mail: scbae@hanyang.ac.kr

Accepted for publication February 8, 2006.




Return to July 2006 Table of Contents



© 2006. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.